Combo Immunotherapy Produces Distinct Waves of Cancer-Fighting T Cells

With a new tool, Penn Medicine researchers have shown how two checkpoint inhibitor therapies work together to recruit new cancer-fighting T cells with each dose, challenging assumptions about a common drug combination for melanoma treatment. “We envision that this more precise method of immune monitoring could be applied to clinical trials in several ways,” Alexander Huang says.